SL52129: Drug targets in the immune system
[Page last updated: 15 August 2024]
Academic Year: | 2024/25 |
Owning Department/School: | Department of Life Sciences |
Credits: | 5 [equivalent to 10 CATS credits] |
Notional Study Hours: | 100 |
Level: | Masters UG & PG (FHEQ level 7) |
Period: |
|
Assessment Summary: | EXOB 100% |
Assessment Detail: |
|
Supplementary Assessment: |
|
Requisites: | Students are expected to have a basic understanding of the immune system and processes. |
Learning Outcomes: |
On successful completion of this unit, the student should be able to:
Synthesise an in-depth knowledge of recently identified target molecules and processes in the immune system. Critically evaluate the role of these targets in particular therapeutic areas.
Utilise a range of ICT and cognitive skills in acquiring knowledge and understanding and applying them to complex, incomplete or contradictory situations. |
Synopsis: | In this unit you will:
- explore recent developments in understanding the immune system and its role in human diseases as well as examine how such understanding can lead to identification and exploitation of novel drug targets for future therapy.
- develop your knowledge of recently identified target molecules and processes in the immune system and give examples of the role of these targets in particular therapeutic areas. |
Content: | A range of topics will be discussed focusing on molecular target linking to cellular process linking to therapeutic area.
Topics will be selected based on their currency at a given time - Examples may include mast cell degranulation, apoptosis, chemotaxis, inflammation, inflammasome processing linking to respiratory, inflammatory, and autoimmune disease states such as allergy, rheumatoid arthritis, asthma. |
Course availability: |
SL52129 is Optional on the following courses:Department of Life Sciences
|
Notes:
|